Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study
Crossref DOI link: https://doi.org/10.1186/s12883-017-0794-5
Published Online: 2017-01-28
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saida, Takahiko
Itoyama, Yasuto
Kikuchi, Seiji
Hao, Qi
Kurosawa, Takayoshi
Ueda, Kengo
Auberson, Lixin Zhang
Tsumiyama, Isao
Nagato, Kazuo
Kira, Jun-ichi